Sanofi and GSK take COVID-19 vaccine into Phase 3 study
Sanofi and GSK have started the Phase 3 study for their COVID-19 vaccine candidate: eying up potential regulatory authorization in Q4, 2021.
Archives for May 27, 2021
Merck rolls out new lipid technology nine months ahead of schedule
Germany’s Merck KGaA has launched a new synthetic cholesterol product that it says will boost capacity for its lipid delivery tools by 50 times.
UPS: ‘The market for drugs and therapies requiring cold storage is growing at a rapid rate’
UPS Healthcare says it has invested in its suite of cold chain technologies on the back of ‘unreal growth’ in the pharmaceutical cold chain market.